Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic

March 10, 2025 updated by: IRCCS SYNLAB SDN

The aim of this research protocol is to evaluate the adherence to the Mediterranean diet in patients suffering from recurrent kidney stones and osteometabolic diseases. Results of the study will allow to assess the dietary habits of patients with the above diseases. Given the universal prevalence of nephrolithiasis and osteometabolic diseases, the knowledge of these data appears crucial for the proper management of the dietary approach to prophylaxis secondar

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Italy
- - Naples, Italy, 80143
    - Recruiting
    - Irccs Synlab Sdn
    - Contact:
      
      Monica Franzese, PhD
      
      Phone Number: +393334041413
      
      Email: direzionescientifica.irccssdn@synlab.it

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Adult
Older Adult

Accepts Healthy Volunteers

Sampling Method

Probability Sample

Study Population

Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years

Description

Inclusion Criteria:

Patients with idiopathic relapsing nephrolithiasis with evidence instrumental of bilateral renal stones or emission of more than one stone in the past 5 years

Exclusion Criteria:

Patients who had albumin-corrected plasma calcium levels > 11.0 mg/dl at the time of the first determination of serum levels of 25 OH vitamin D;
Patients who had glomerular filtration rate < 60 mL/min/1.73 m2;
Patients who had positive personal history of chronic granulomatous disease;
pregnancy patients;
Positive personal history for morphological abnormalities of the excretory system;
incomplete data collection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Patient eating habits Time Frame: 1-36 months	Questionaries to detect the patients eating habits.	1-36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

IRCCS SYNLAB SDN

Collaborators

Department of Clinical Medicine and Surgery - University of Naples Federico II

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2023

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

March 10, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)